Research Article

Association of FTO Mutations with Risk and Survival of Breast Cancer in a Chinese Population

Table 2

ORs and 95% CIs for breast cancer in relation to polymorphisms of FTO gene.

SNPGenotypesCases, (%)Controls, (%)OR (95% CI)OR (95% CI) trend

rs9939609TT389 (72.6)408 (76.0)1.001.000.13
TA130 (24.2)119 (22.1)1.14 (0.86–1.52)1.14 (0.85–1.52)
AA17 (3.2)10 (1.9)1.78 (0.80–3.93)1.69 (0.75–3.80)
AA + TA147 (27.4)129 (24.0)1.19 (0.90–1.57)1.18 (0.89–1.56)

rs1477196GG272 (50.7)231 (43.0)1.001.000.004
GA231 (43.1)254 (47.3)0.77 (0.60–0.99)0.79 (0.61–1.02)
AA33 (6.2)52 (9.7)0.54 (0.34–0.86)0.56 (0.34–0.90)
AA + GA264 (49.2)306 (57.0)0.73 (0.58–0.93)0.75 (0.59–0.96)

rs6499640GG361 (67.5)375 (69.8)1.001.000.44
GA159 (29.7)148 (27.6)1.12 (0.85–1.46)1.13 (0.86–1.48)
AA15 (2.8)14 (2.6)1.10 (0.52–2.32)1.11 (0.52–2.35)
AA + GA174 (32.5)162 (30.2)1.11 (0.86–1.44)1.13 (0.87–1.47)

rs16953002GG217 (40.5)250 (46.5)1.001.000.005
GA232 (43.3)231 (43.0)1.16 (0.90–1.50)1.13 (0.87–1.46)
AA87 (16.2)56 (10.4)1.80 (1.23–2.63)1.77 (1.20–2.61)
AA + GA319 (59.5)287 (53.5)1.28 (1.01–1.64)1.25 (0.98–1.60)

rs11075995TT249 (46.5)236 (44.0)1.001.000.24
TA244 (45.5)247 (46.0)0.93 (0.73–1.20)0.97 (0.75–1.25)
AA43 (8.0)54 (10.0)0.75 (0.48–1.17)0.80 (0.51–1.25)
AA + TA287 (53.5)301 (56.0)0.90 (0.71–1.15)0.94 (0.73–1.20)

rs1121980GG360 (67.2)377 (70.2)1.001.000.19
GA154 (28.7)145 (27.0)1.11 (0.85–1.45)1.11 (0.84–1.46)
AA22 (4.1)15 (2.8)1.54 (0.79–3.02)1.42 (0.71–2.82)
AA + GA176 (32.8)160 (29.8)1.15 (0.89–1.49)1.13 (0.87–1.48)

Adjusted for age.
Adjusted for age, age at menarche, BMI, ever breastfeeding, and education.
trend is test of trend for the number of copies of the variant allele (0, 1 and 2).